References
- Mirza AZ, Shamshad H. Preparation and characterization of doxorubicin functionalized gold nanoparticles. Eur J Med Chem. 2011;46:1857–1860.
- Lince F, Bolognesi S, Stella B, et al. Preparation of polymer nanoparticles loaded with doxorubicin for controlled drug delivery. Chem Eng Res Des. 2011;89:2410–2419.
- Namdari M, Eatemadi A. Cardioprotective effects of curcumin-loaded magnetic hydrogel nanocomposite (nanocurcumin) against doxorubicin-induced cardiac toxicity in rat cardiomyocyte cell lines. Artif Cells Nanomed Biotechnol. 2017;45:731–739.
- Xi L, Zhu S-G, Das A, et al. Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications. Nitric Oxide. 2012;26:274–284.
- Gaumet M, Vargas A, Gurny R, et al. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm. 2008;69:1–9.
- Cheng T, Liu J, Ren J, et al. Green tea catechin-based complex micelles combined with doxorubicin to overcome cardiotoxicity and multidrug resistance. Theranostics. 2016;6:1277–1292.
- Lv L, Qiu K, Yu X, et al. Amphiphilic copolymeric micelles for doxorubicin and curcumin co-delivery to reverse multidrug resistance in breast cancer. J Biomed Nanotechnol. 2016;12:973–985.
- Suchocki P, Misiewicz I, Skupinska K, et al. The activity of Selol in multidrug-resistant and sensitive human leukemia cells. Oncol Rep. 2007;18:893–899.
- de Souza LR, Muehlmann LA, Dos Santos MSC, et al. PVM/MA-shelled selol nanocapsules promote cell cycle arrest in A549 lung adenocarcinoma cells. J Nanobiotechnol. 2014;12:1–17.
- de Souza LR, Muehlmann LA, Matos LC, et al. Antitumor activity and systemic effects of PVM/MA-shelled selol nanocapsules in lung adenocarcinoma-bearing mice. Nanotechnology. 2015;26:505101.
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.
- Longo JPF, Muehlmann LA, Miranda-Vilela AL, et al. Prevention of distant lung metastasis after photodynamic therapy application in a breast cancer tumor model. J Biomed Nanotechnol. 2016;12:689–699.
- Conway MA, Madrigal-estebas L, Mcclean S, et al. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells. Vaccine. 2001;19:1940–1950.
- Muehlmann LA, Ma BC, Longo JPF, et al. Aluminum-phthalocyanine chloride associated to poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as a new third-generation photosensitizer for anticancer photodynamic therapy. Int J Nanomedicine. 2014;9:1199–1213.
- Guhagarkar SA, Gaikwad RV, Samad A, et al. Polyethylene sebacate-doxorubicin nanoparticles for hepatic targeting. Int J Pharm. 2010;401:113–122.
- Beljebbar A, Sockalingum GD, Angiboust JF, et al. Comparative FT SERS, resonance Raman and SERRS studies of doxorubicin and its complex with DNA. Spectrochim Acta Part A Mol Spectrosc. 1995;51:2083–2090.
- Liang L, Huang D, Wang H, et al. In situ surface-enhanced raman scattering spectroscopy exploring molecular changes of drug-treated cancer cell nucleus. Anal Chem. 2015;87:2504–2510.
- Chamberlain GR, Tulumello DV, Kelley SO. Targeted delivery of doxorubicin to mitochondria. ACS Chem Biol. 2013;8:1389–1395.
- Notingher I, Verrier S, Haque S, et al. Spectroscopic study of human lung epithelial cells (A549) in culture: living cells versus dead cells. Biopolymers. 2003;72:230–240.
- Movasaghi Z, Rehman S, Rehman IU. Raman spectroscopy of biological tissues. Appl Spectrosc Rev. 2007;42:493–541.
- Biswas S, Torchilin VP. Nanopreparations for organelle-specific delivery in cancer. Adv Drug Deliv Rev. 2014;66:26–41.
- Joanitti GA, Ganassin R, Rodrigues MC, et al. Nanostructured systems for the organelle-specific delivery of anticancer drugs. Mini Rev Med Chem. 2017;17:224–236.
- Vakili MR, Abyaneh HS, Molavi O, et al. Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX. Mol Pharm. 2014;11:2640–2649.
- Mizutani H, Tada-Oikawa S, Hiraku Y, et al. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci. 2005;76:1439–1453.
- Qi Y, Fu X, Xiong Z, et al. Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer. PLoS One. 2012;7:e31539.